0
2021
Carrier Screening Market

Carrier Screening Market

by Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, and Others), and End User (Hospitals & Clinics, Reference Laboratories, Physician Offices, and Others)- Global Opportunity Analysis and Industry Forecast, 2021-2030
Update Available On-Demand

Report Code: A11271
Pages: 361
Oct 2021 | 1935 Views
Author(s) : Sushant T , Onkar S
Tables: 146
Charts: 42
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Carrier Screening Market

Request Now !

Carrier Screening Market Insights - 2030

The carrier screening market size was valued at $1,378.06 million in 2020, and is projected to reach $4,002.05 million by 2030, growing at a CAGR of 11.5% from 2021 to 2030. Carrier screening is diagnosis of abnormal chromosomal or genetic disorder from a carrier person who inherits one abnormal gene from one of their parents. Carriers often show no symptoms of the genetic disorder that they transfer an abnormal gene. The growth of the carrier screening market is driven by surge in incidence of genetic diseases, increase in availability & affordability of tests, and rise in advanced product launches.

Moreover, increase in emphasis on early disease detection & prevention, surge in demand for personalized medicine, and rise in application of screening tests in genetic disorders are expected to foster the growth of the global forecast period. Furthermore, increase in applications of carrier screening in genetic disorder fields, various initiatives & funding from government & private bodies for large-scale carrier screening projects, and decline in cost of screening notably contribute toward the growth of the global market. 

Carrier-Screening-Market-2021-2030

Prominent players in the global carrier screening market have opted various strategies such as product launches, acquisition, and investments in R&D for advancement in carrier screening to strengthen their position in the market and sustain the competitive environment. One of the major driving factors for the carrier screening market is the increase in prevalence of fetal chromosomal abnormalities and genetic disorders.

Impact Of Covid-19 On Carrier Screening Market (Pre And Post Analysis)

Coronavirus (COVID-19) was discovered in December 2019 in Hubei province of Wuhan city in China. The disease is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted among humans. 

After its discovery in Wuhan, the disease rapidly spread to other parts of the globe. Moreover, this virus causes various symptoms in patients, which range from common symptoms to serious symptoms. For instance, common symptoms include fever, dry cough, and fatigue. However, serious symptoms include difficulty in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement. Furthermore, the virus has high potential of lethality in geriatric population. On 11th March 2020, the World Health Organization made an assessment that COVID-19 can be characterized as pandemic. In addition, there are only a few vaccines that received emergency approvals for COVID-19 type or prevention. Thus, social distancing is observed as the most important measure to stop the spread of this disease. Furthermore, to maintain social distancing, various countries across the world have adopted nationwide lockdowns. 

The COVID-19 pandemic is an unprecedented global public health challenge, and is anticipated to have a negative impact on the carrier screening market. Pregnant or recently pregnant women with COVID-19 are more likely to be admitted to the intensive care unit or need respiratory support when compared with non-pregnant women of reproductive age. Pregnant women with COVID-19 were also more likely to give birth prematurely. For instance, as per the data published by the World Health Organization in 2020, 1 in 4 of all babies born to women with COVID-19 were admitted to a neonatal unit, but data on causes of preterm births or indications for admission to neonatal units among these babies is lacking. Stillbirth and newborn death rates however were low. 

Segment Review By Type

Depending on carrier screening type, the market is bifurcated into expanded carrier screening and targeted disease carrier screening. The expanded carrier screening segment is further dived into customized panel testing and predesigned panel testing. The expanded carrier screening segment accounted for the majority of market share of the global market in 2020, owing to advancement in DNA sequencing, polymerase chain reaction, microarrays, and other technologies in the field of carrier screening. Moreover, increase in cases of genetic disorder is boosting the carrier screening market growth.

Carrier Screening Market- Global Opportunity Analysis and Industry Forecast, 2021-2030
By Type

Your browser does not support the canvas element.

Expanded Carrier Screening segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Segment Review By Technology

On the basis of technology, the carrier screening market is categorized into DNA sequencing, polymerase chain reaction, microarrays, and other technologies. The DNA sequencing segment accounted for the majority of market share of the global market in 2020, and is expected to remain dominant during the forecast period, owing to advancements in genetic analysis tools, such as assays based on next-generation sequencing and microarray technologies, molecular diagnostics, and advancing the type for heritable diseases. 

Carrier Screening Market- Global Opportunity Analysis and Industry Forecast, 2021-2030
By Technology

Your browser does not support the canvas element.

DNA Sequencing segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Segment Review By End-user

By end user, the market is segregated into hospitals & clinics, reference laboratories, physician offices, and others. The hospital & clinics segment accounted for maximum market revenue in 2020, and is anticipated to maintain its dominant position during the forecast period. This is attributed to increase in cases of genetic disorders and advancements in carrier screening.

Carrier Screening Market- Global Opportunity Analysis and Industry Forecast, 2021-2030
By End User

Your browser does not support the canvas element.

Hospitals and Clinics segment held a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Segment Review By Region

Region wise, the carrier screening market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the market in 2020, accounting for the highest share, and is anticipated to maintain this trend throughout the forecast period. This is attributed to increase in case of pulmonary conditions, hematological conditions, and neurological conditions in the region, which foster the demand for carrier screening. However, Asia-Pacific is projected to register the highest growth rate from 2021 to 2030.

Carrier Screening Market- Global Opportunity Analysis and Industry Forecast, 2021-2030
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America was holding a dominant position in 2020 and would continue to maintain the lead over the analysis period.

Get more information on this report : Request Sample Pages

This report provides comprehensive competitive analysis and profiles of prominent market players such as Eurofins Scientific, Invitae Corporation, Opko Health, Fulgent Genetics Inc., Quest Diagnostics Incorporated, Natera Inc. Myriad Genetics, Illumina Inc., Thermo Fisher Scientific Inc., and Luminex Corporation.

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current trends and future estimations from 2020 to 2030, which assists to identify the prevailing carrier screening market opportunities. 
  • An in-depth carrier screening market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
  • Key market players within the carrier screening market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the carrier screening market.

Key Market Segments

By Type    

  • Expanded Carrier Screening    
  • Customized Panel Testing
  • Predesigned Panel Testing
  • Targeted Disease Carrier Screening

By Technology

  • DNA Sequencing    
  • Polymerase Chain Reaction    
  • Microarrays    
  • Others

By End User

  • Hospitals & Clinics    
  • Reference Laboratories    
  • Physician Offices
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy 
    • France
    • UK
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Eurofins Scientific
  • Invitae Corporation
  • Opko Health
  • Fulgent Genetics Inc.
  • Quest Diagnostics Incorporated
  • Natera Inc.
  • Myriad Genetics
  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • Luminex Corporation.
 

Loading Table Of Content...


 
 

The utilization of carrier screening is expected to increase in the forecast period, due to rise in prevalence of genetic disorders and increase in applications of carrier screening in clinical diagnostic and drug discovery. Increase in interest of healthcare providers and biofuel owing to several benefits offered by carrier screening is boosting the market growth. Carrier screening involves direct genetic analysis, and it gives information about relative abundance of different organisms and the community structure. While the market is growing at a steady rate in developed nations, Asia-Pacific and LAMEA are expected to offer potential growth opportunities to the key players.

Moreover, surge in prevalence of genetic disorders, increase in pregnancy rate, increasing prevalence of chronic diseases, and rise in healthcare expenditure are some prominent factors driving the market. In addition, high cost involved and limited awareness in developing world may hinder the growth of the global carrier screening market.

Advancements in DNA sequencing & next-generation sequencing and surge in expansion of carrier screening applications drive the market growth. In addition, increase in carrier screening, advancements in medical technology leading to developments in carrier screening, significant applications of carrier screening in genetic diagnostic fields, initiatives & funding from government & private bodies for large-scale sequencing projects, and decline in cost of sequencing are the key factors that contribute toward the growth of the market worldwide. In addition, key players in this industry have focused on expanding their presence in the emerging economies, which is anticipated to drive the market growth.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
FREQUENTLY ASKED QUESTIONS?

A. The total market value of Carrier Screening Market is $1,378.06 million in 2020

A. The forecast period in the report is from 2021 to 2030

A. The market value of Carrier Screening Market in 2020 was $4,002.05 Million

A. The base year for the report is 2020

A. Yes, Carrier Screening companies are profiled in the report

A. The top companies that hold the market share in Carrier Screening Market are Eurofins Scientific, Invitae Corporation, Opko Health, Fulgent Genetics Inc., Quest Diagnostics Incorporated, Natera Inc. Myriad Genetics, Illumina Inc., Thermo Fisher Scientific Inc., and Luminex Corporation.

A. No, there is no value chain analysis provided in the Carrier Screening Market report

A. The key trends in the Carrier Screening Market are such as significant applications of carrier screening in genetic disorder fields, various initiatives, and funding from government & private bodies for large-scale carrier screening projects and decline in cost of screening.

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS

Purchase Full Report of
Carrier Screening Market

Start reading instantly.
This Report and over 19,311+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Oct 2022 - Oct 2023)
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2022 - Oct 2023)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2022 - Oct 2023)
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2022 - Oct 2023)
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Oct 2022 - Oct 2023)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers